President Donald Trump on Thursday signed an executive order directing the U.S. Attorney General to accelerate the process of reclassifying marijuana under federal law, marking a significant shift in national drug policy while stopping short of full legalization.

The move to Schedule III marks the greatest change to U.S. drug laws since 1970 and represents a new future for the $32 billion cannabis industry.

Rescheduling the drug does little more than offer a tax cut to an industry that extracts enormous profit from addiction.

U.S. Rep. Greg Steube says President Donald Trump’s order to reschedule marijuana offers a window for Congress to pass his bill doing just that.

The Texas Hemp Business Council (THBC) issued the following statement in response to President Donald Trump’s executive order directing the expedited rescheduling of marijuana to Schedule III under the Controlled Substances Act and urging Congress to ensure patient access to full-spectrum,

Every country has a published controlled substance list, but the named substances are only common examples. The list also covers analogs and defined chemical space around these substances, which complicates matters for chemical suppliers, manufacturers ...

As the third pandemic-era waiver allowing virtual prescribing of controlled substances sunsets, more than 180 telemedicine providers and advocates are asking OMB and DEA to act immediately to protect patients.

As providers are becoming more comfortable with delivering care via telemedicine technologies, many of them are looking to explore services other than low acuity triage consults. One area of patient service opportunity – and particular confusion – is ...